Assignee profile:

BRIDGE PHARMA, INC.

City:

Sarasota, Florida

Country:

United States

Published Applications:

33

Last publication date:

2021-06-24

Patent Grants:

25

Last grant date:

2021-12-14

Top Inventors for applications by BRIDGE PHARMA, INC.

These are the the leading inventors for applications assigned to BRIDGE PHARMA, INC.:

Recent patent applications by BRIDGE PHARMA, INC.

BRIDGE PHARMA, INC. based in Sarasota, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-06-24 ✅ Patent 11,197,851 granted on 2021-12-14
US20210186945A1
Human necessities

Methods of treatment of asthma and COPD

#2 | 2020-11-12 ✅ Patent 10,959,992 granted on 2021-03-30
US20200352927A1
Human necessities

Methods of treatment of asthma and COPD

#3 | 2017-04-20 ✅ Patent 9,694,003 granted on 2017-07-04
US20170105987A1
Human necessities

Formulations and methods for treating high intraocular pressure

#4 | 2016-08-11 ✅ Patent 9,439,895 granted on 2016-09-13
US20160228426A1
Human necessities

Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients

#5 | 2016-07-07 ✅ Patent 9,808,419 granted on 2017-11-07
US20160193143A1
Human necessities

Medicinal treatment of dermal infectious disorders with norketotifen

#6 | 2015-12-03 ✅ Patent 9,333,199 granted on 2016-05-10
US20150342944A1
Human necessities

Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders

#7 | 2015-10-01 ✅ Patent 9,345,697 granted on 2016-05-24
US20150272942A1
Human necessities

Methods of treatment of non-histaminic pruritus

#8 | 2015-10-01
US20150272941A1
Human necessities

MEDICINAL TREATMENT OF CHRONIC PULMONARY INFLAMMATORY DISEASES WITH NORKETOTIFEN

#9 | 2015-02-12 ✅ Patent 9,138,431 granted on 2015-09-22
US20150045392A1
Human necessities

Methods of treatment of histamine H-4 receptor-related pruritus

#10 | 2014-10-09 ✅ Patent 8,969,385 granted on 2015-03-03
US20140303091A1
Human necessities

Ocular formulations of norketotifen

#11 | 2014-05-01
US20140120121A1
Human necessities

MEDICINAL TREATMENT OF ATOPIC INFLAMMATORY DISEASES

#12 | 2014-04-24 ✅ Patent 8,778,971 granted on 2014-07-15
US20140113936A1
Human necessities

Medicinal treatment of dermal diseases in companion animals

#13 | 2013-10-15 ✅ Patent 8,557,846 granted on 2013-10-15
US13739090
-

Medicinal treatment of dermal diseases in dogs

#14 | 2013-04-11 ✅ Patent 8,445,542 granted on 2013-05-21
US20130090295A1
Human necessities

Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals

#15 | 2012-01-19 ✅ Patent 8,383,685 granted on 2013-02-26
US20120015895A1
Human necessities

Use of RR/SR-ractopamine

#16 | 2011-12-01
US20110294897A1
Human necessities

Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion

#17 | 2011-09-08
US20110218218A1
Human necessities

Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain

#18 | 2010-07-22 ✅ Patent 8,071,653 granted on 2011-12-06
US20100184865A1
Human necessities

Use of RR/SR-ractopamine

#19 | 2010-07-15
US20100179114A1
Chemistry; metallurgy

S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents

#20 | 2010-05-27 ✅ Patent 8,765,787 granted on 2014-07-01
US20100130550A1
Human necessities

Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen

#21 | 2010-04-29 ✅ Patent 8,741,930 granted on 2014-06-03
US20100105734A1
Human necessities

Treating xerophthalmia with norketotifen

#22 | 2009-06-11 ✅ Patent 7,872,025 granted on 2011-01-18
US20090149502A1
Chemistry; metallurgy

Optically active isomers of ketotifen and therapeutically active metabolites thereof

#23 | 2009-06-04 ✅ Patent 7,723,392 granted on 2010-05-25
US20090143480A1
Human necessities

Use of RR/SR-ractopamine

#24 | 2009-05-28
US20090137628A1
Human necessities

Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain

#25 | 2009-01-01 ✅ Patent 7,985,775 granted on 2011-07-26
US20090004235A1
Human necessities

Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals

#26 | 2008-11-20 ✅ Patent 7,557,128 granted on 2009-07-07
US20080287498A1
Chemistry; metallurgy

Optically active isomers of ketotifen and therapeutically active metabolites thereof

#27 | 2007-12-06
US20070282010A1
Human necessities

Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals

#28 | 2007-06-05 ✅ Patent 7,226,934 granted on 2007-06-05
US10069663
-

Optically active isomers of ketotifen and therapeutically active metabolites thereof

#29 | 2006-12-28 ✅ Patent 7,390,816 granted on 2008-06-24
US20060293356A1
Human necessities

Methods for treating urinary incontinence in patients suffering from memory disorders

#30 | 2006-11-28 ✅ Patent 7,141,696 granted on 2006-11-28
US10850868
-

Smooth muscle spasmolytic agents

#31 | 2006-04-13 ✅ Patent 7,718,674 granted on 2010-05-18
US20060079559A1
Chemistry; metallurgy

Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine

#32 | 2006-04-13
US20060079558A1
Chemistry; metallurgy

R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics

#33 | 2005-02-24 ✅ Patent 6,974,820 granted on 2005-12-13
US20050043342A1
Human necessities

Methods for treating urinary incontinence and other disorders using trospium

Also check out Bridge Pharma, Inc.'s (Sarasota, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

17692 ⎘